Novo Nordisk's Wegovy Pill Shows Similar Weight-Loss to Its Shot, Study Finds

Core Insights - The production of a new weight loss pill is currently underway, which has demonstrated an average weight loss of 16.6% in patients and is awaiting regulatory approval in the U.S. [1] Group 1 - The pill has helped patients achieve an average weight loss of 16.6% [1] - Production of the pill is actively in progress [1] - The pill is pending regulatory approval in the U.S. [1]